Brief: Aethlon Medical's Hemopurifier® Shows Changes In Extracellular Vesicles, Extracellular Micrornas, And T Cell Numbers In Australian Oncology Clinical Trial
07/10/2025 13:35
Oct 7 (Reuters) - Aethlon Medical Inc AEMD.O: AETHLON MEDICAL'S HEMOPURIFIER® SHOWS CHANGES IN EXTRACELLULAR VESICLES, EXTRACELLULAR MICRORNAS, AND T CELL NUMBERS IN AUSTRALIAN ONCOLOGY CLINICAL TRIAL Source text: ID:nPnxD2x7a Further company coverage: AEMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology